The body treatment set to transform New Zealand’s cosmetic medicine market
Following in the (big) footsteps of the raved about beauty treatment dubbed the “injectable moisturiser”, comes its sidekick, specifically targeting the neck down.
PROFHILO® first launched in 2015, then finally—albeit we still bet Australia—made its way to New Zealand shores in 2020. It captured global interest in cosmetic clinics across the globe and ever since consumers can’t seem to get enough. Now, let us introduce you to PROFHILO® BODY – the new injectable specifically designed for use on the body, targeting previously hard to treat areas, such as the decolletage, abdomen, top of the knees and arms.
PROFHILO® BODY, developed by international pharma company IBSA, is a new concept in the dermal injectables industry. The treatment offers an overarching approach to skin ageing, beyond currently available solutions, while creating a new category in itself within the world of aesthetic medicine.
As an industry leader in the field of aesthetic medicine and in the production of ultrapurehyaluronic acid, IBSA Derma advocates greater care for the body, equal to that devoted to the face.
What is PROFHILO® BODY?
PROFHILO®BODY is made up of exactly the same ingredient as its predecessor. The treatment involves having hyaluronic acid (a hydrating powerhouse) injected into the face – but before you ask, no, it’s not the same as fillers. It contains the highest concentration of Ultrapure hyaluronic acid on the market, which resembles manuka honey in the way it flows into the different layers of skin. When injected, it stimulates the skin’s natural synthesis of collagen for plumped and firmed up skin. Unlike fillers, PROFHILO® diffuses into the skin to boost your overall complexion rather than staying put in one area to fill creases or plump cheekbones or lips.
The result is lifted tissue, improved texture, intense hydration, and an overall improvement in the skin quality with firmer skin and a significant reduction in wrinkles severity.
“PROFHILO® BODY is a real anti-ageing treatment for men and women of all ages and is set to transform the market just as it PROFHILO® has,” says George Kypreos, Managing Director of Dermocosmètica, the exclusive distributor of the innovative Italian-made product.
One of the first to offer the new treatment is Clinic 42, one of New Zealand’s most trusted cosmetic medicine clinics. Clinic 42 specialise in offering a comprehensive international range of cutting-edge, medically based and researched, skin enhancement and rejuvenation procedures. They have been using PROFHILO® for the face and neck in their Auckland-based clinic for a number of years with exceptional results.
Leading appearance medicine expert Dr Ellen Selkon from Clinic 42 comments, “PROFHILO® BODY is the ONLY injectable treatment on the market specifically designed for the treatment of body skin laxity and is particularly recommended for the brachial area and abdomen. The perfect lunchtime treatment, it requires minimal downtime and is very safe to use, with only 10 injection points for each area needed. Being a non-invasive treatment, it reduces the possibility of bruising and swelling, while maximising the diffusion of the product in the tissues.”
Clinic 42 co-founder, the highly experienced Dr Joanna Romanowska also comments, “This treatment differs from other dermal filler and skin boosters because of its tissue integration ability. From the injector’s perspective, it can be performed quickly and efficiently, with less discomfort to the patient.”
The recommended number of sessions is two, at 4-week intervals,, with results lasting for at least six months. It can be used as a standalone treatment or in conjunction with other treatments.
PROFHILO® BODY is now available in over 200 cosmetic practices across New Zealand, distributed via medical aesthetics distributor Dermocosmètica.